Centessa Pharmaceuticals Ltd.

Centessa Pharmaceuticals Ltd.

Centessa Pharmaceuticals Ltd.

Overview
Date Founded

2020

Headquarters

The Dorothy Hodgkin Building,Babraham Research Campus,Cambridge, Cambridgeshire CB22 3FH

Type of Company

Private

Industries

Pharmaceuticals
Holding Companies

Company Description

Centessa Pharmaceuticals Ltd. operates as pharmaceutical company that develops medicines. The company was founded on October 26, 2020 and is headquartered in Cambridge, the United Kingdom.

Executives & Employees

Chief Executive Officer

Chief Financial Officer

Chief Medical Officer

Chief Accounting Officer

Chief Administrative Officer

Director

Board of Directors

Co-Founder & Partner at Medicxi Ventures (Jersey) Ltd.

Professional at GlaxoSmithKline Plc

Managing Director at Foresite Capital Management LLC

Co-Founder & Managing Director at VV Manager LLC

Chief Executive Officer & Director at CRISPR Therapeutics AG

Chief Executive Officer at Centessa Pharmaceuticals Ltd.

Head-Strategy & Policy at Alphabet, Inc.

Partner at Apple Tree Partners

Paths to Centessa Pharmaceuticals Ltd.
Potential Connections via
Relationship Science
You
Centessa Pharmaceuticals Ltd.
Recent Transactions
Details Hidden

Centessa Pharmaceuticals Ltd. purchases ApcinteX Ltd.

Investors
Details Hidden

Ecor1 Capital manages the EcoR1 Capital Fund LP, a fundamental long/short equity hedge fund focusing on investment opportunities in the biotechnology sector. The firm employs an innovative, process-driven approach that is based on a value philosophy which attempts to manage risk in the volatile biotechnology sector. The fund focuses on outliers not typically analyzed as part of value based diligence; human capital in addition to deep scientific and financial analysis. Ecor1 Capital is committed to going beyond the usual monetary investment in companies and engages directly with management to identify opportunities for efficiencies and growth, and where necessary, invests their own human capital resources to help mediate much of the risk that is inherent in the sector. The goal of combining this innovative perspective and process is generation of uncorrelated returns relative to the biotechnology sector and to the overall market.

Details Hidden

Wellington Management Co. LLP (Private Equity) focuses in companies located in US. The firm invests in consumer discretionary, technology, financial services, biotech, and health care. They provide capital for growth and later stage capital requirement.

Details Hidden

Cormorant invests in companies primarily located in North America. The firm targets companies in sectors such as life-science and biotech. It provides financing for early stage capital requirements.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Centessa Pharmaceuticals Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Centessa Pharmaceuticals Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Centessa Pharmaceuticals Ltd..